DKNG analyst scorecard
103 rating actions on DKNG in the last 12 months. Of 147 price targets that resolved, 17 were reached while they stood, 124 were replaced by the same firm first, and 6 fell short at their deadline. Ratings: 94% Buy-type, 6% Hold-type, 0% Sell-type. Consensus target $34, 64% above the last close.
Checked through 2026-10-29 · last close $20.61 (2026-10-29). Rebuilt every morning.
Targets reached while they stood
11.6% 17 of 147
Replaced before the deadline
84.4%
Short at the deadline
4.1%
Ratings vs XLY
1 of 24
Buy / Hold / Sell, 12 mo
94 / 6 / 0%
Consensus target
$34 +64.2%
What the Holds say: 5 Hold-type ratings on DKNG in the last 12 months carried a median target +16% from the price on the day; 0% sat below it.
Firm by firm
| Firm | Latest rating | Date | Latest target | Targets reached | Replaced early | Resolved | Ratings vs sector |
|---|---|---|---|---|---|---|---|
| JPMorgan | Overweight | 2026-10-20 | $30 | 1 | 7 | 8 | 0 of 1 |
| Truist Securities | Buy | 2026-10-20 | $26 | 1 | 8 | 9 | 0 of 1 |
| Citigroup | Buy | 2026-10-12 | $28 | 1 | 7 | 8 | 0 of 1 |
| Barclays | Overweight | 2026-08-10 | $34 | 1 | 9 | 10 | 0 of 1 |
| Stifel | Buy | 2026-10-26 | $32 | 0 | 8 | 8 | 0 of 1 |
| Needham | Buy | 2026-09-18 | $35 | 0 | 10 | 10 | 0 of 1 |
| Macquarie | Outperform | 2026-10-07 | $34 | 1 | 5 | 6 | 0 of 1 |
| BTIG | Buy | 2026-10-29 | $26 | 1 | 9 | 10 | 0 of 1 |
| Guggenheim | Buy | 2026-10-07 | $30 | 0 | 7 | 7 | 0 of 1 |
| Citizens | Market Outperform | 2026-09-24 | $35 | 0 | 5 | 5 | — |
| Mizuho | Outperform | 2026-05-12 | $45 | 0 | 5 | 5 | 0 of 1 |
| Freedom Capital Markets | Buy | 2026-05-21 | $30 | 1 | 0 | 1 | — |
| Argus Research | Hold | 2026-03-17 | — | — | — | 0 | — |
| Goldman Sachs | Buy | 2026-02-17 | $31 | — | — | 0 | — |
| Oppenheimer | Outperform | 2026-02-17 | $35 | 0 | 1 | 1 | 0 of 1 |
| Wells Fargo | Overweight | 2026-10-19 | $30 | 1 | 4 | 5 | — |
| Canaccord Genuity | Buy | 2026-10-23 | $40 | 0 | 4 | 4 | 0 of 1 |
| Susquehanna | Positive | 2026-10-08 | $27 | 0 | 7 | 7 | 0 of 1 |
| Bernstein | Outperform | 2026-09-03 | $29 | 0 | 2 | 2 | — |
| Benchmark | Buy | 2026-08-07 | $30 | 2 | 5 | 7 | 0 of 1 |
| Bank of America | Buy | 2026-10-05 | $27 | 2 | 1 | 3 | — |
| TD Cowen | Buy | 2026-07-10 | $35 | 2 | 1 | 3 | 0 of 1 |
| BMO Capital | Outperform | 2026-03-03 | $50 | 0 | 1 | 1 | — |
| Morgan Stanley | Overweight | 2026-10-19 | $31 | 0 | 6 | 6 | 0 of 1 |
| UBS | Buy | 2026-09-18 | $48 | 0 | 3 | 3 | 0 of 1 |
| Wolfe Research | Outperform | 2026-09-02 | $40 | — | — | 0 | — |
| Deutsche Bank | Hold | 2026-07-09 | $28 | — | — | 0 | — |
| MoffettNathanson | Neutral | 2026-04-24 | $27 | 1 | 0 | 1 | — |
Counts for one firm on one stock are small and move together; they are a record, not a grade. Neither the firms nor DKNG carry a letter here. Why →
Every call, last 12 months
| Date | Firm | Rating | Action | Price at call | Target | Target status | Move in the 30 days before |
|---|---|---|---|---|---|---|---|
| 2026-10-29 | BTIG | Buy | maintained | $20.61 | $26 | running to 2027-10-29 | +5.2% |
| 2026-10-26 | Stifel | Buy | maintained | $21.22 | $32 | running to 2027-10-26 | -3.6% |
| 2026-10-23 | Canaccord Genuity | Buy | maintained | $20.91 | $40 | running to 2027-10-23 | -1.6% |
| 2026-10-20 | JPMorgan | Overweight | maintained | $20.48 | $30 | running to 2027-10-20 | -5.8% |
| 2026-10-20 | Truist Securities | Buy | maintained | $20.48 | $26 | running to 2027-10-20 | -5.8% |
| 2026-10-19 | Morgan Stanley | Overweight | maintained | $19.77 | $31 | running to 2028-04-19 | -9.1% |
| 2026-10-19 | Wells Fargo | Overweight | maintained | $19.77 | $30 | running to 2027-10-19 | -9.1% |
| 2026-10-12 | Citigroup | Buy | maintained | $19.66 | $28 | running to 2027-10-12 | -20.5% |
| 2026-10-08 | Susquehanna | Positive | maintained | $19.87 | $27 | running to 2027-10-08 | -16.8% |
| 2026-10-07 | Macquarie | Outperform | maintained | $19.15 | $34 | running to 2027-10-07 | -20.2% |
| 2026-10-07 | Guggenheim | Buy | maintained | $19.15 | $30 | running to 2027-10-07 | -20.2% |
| 2026-10-05 | Bank of America | Neutral → Buy | upgrade | $19.60 | $27 | running to 2027-10-05 | -18.4% |
| 2026-10-01 | BTIG | Buy | maintained | $19.35 | $25 | replaced 2026-10-29, new $26 | -17.4% |
| 2026-09-24 | Citizens | Market Outperform | maintained | $21.27 | $35 | running to 2027-09-24 | -17.5% |
| 2026-09-18 | UBS | Buy | maintained | $21.75 | $48 | running to 2027-09-18 | -14.1% |
| 2026-09-18 | Needham | Buy | reiterated | $21.75 | $35 | running to 2027-09-18 | -14.1% |
| 2026-09-08 | Citizens | Market Outperform | maintained | $23.87 | $37 | replaced 2026-09-24, new $35 | -0.7% |
| 2026-09-03 | Bernstein | Outperform | maintained | $24.19 | $29 | running to 2027-09-03 | +2.5% |
| 2026-09-02 | Wolfe Research | Outperform | initiated | $24.21 | $40 | running to 2027-09-02 | +3.0% |
| 2026-08-11 | Citigroup | Buy | maintained | $25.34 | $32 | replaced 2026-10-12, new $28 | -4.3% |
| 2026-08-11 | Macquarie | Outperform | maintained | $25.34 | $38 | replaced 2026-10-07, new $34 | -4.3% |
| 2026-08-10 | JPMorgan | Overweight | maintained | $24.27 | $33 | replaced 2026-10-20, new $30 | -8.3% |
| 2026-08-10 | Guggenheim | Buy | maintained | $24.27 | $33 | replaced 2026-10-07, new $30 | -8.3% |
| 2026-08-10 | Barclays | Overweight | maintained | $24.27 | $34 | running to 2027-08-10 | -8.3% |
| 2026-08-07 | Benchmark | Buy | maintained | $24.03 | $30 | running to 2027-08-07 | -11.6% |
| 2026-07-22 | Stifel | Buy | maintained | $22.83 | $38 | replaced 2026-10-26, new $32 | -11.0% |
| 2026-07-20 | Truist Securities | Buy | maintained | $24.32 | $29 | replaced 2026-10-20, new $26 | -7.8% |
| 2026-07-20 | Wells Fargo | Overweight | maintained | $24.32 | $29 | replaced 2026-10-19, new $30 | -7.8% |
| 2026-07-15 | JPMorgan | Overweight | maintained | $25.25 | $34 | replaced 2026-08-10, new $33 | -12.3% |
| 2026-07-10 | TD Cowen | Buy | maintained | $26.48 | $35 | running to 2027-07-10 | -8.0% |
| 2026-07-09 | Deutsche Bank | Hold | maintained | $26.29 | $28 | running to 2027-07-09 | -4.7% |
| 2026-07-01 | Susquehanna | Positive | maintained | $25.77 | $31 | replaced 2026-10-08, new $27 | -2.1% |
| 2026-06-25 | Citizens | Market Outperform | maintained | $23.10 | $36 | replaced 2026-09-08, new $37 | -3.0% |
| 2026-06-24 | Guggenheim | Buy | reiterated | $24.53 | $35 | replaced 2026-08-10, new $33 | -2.4% |
| 2026-06-22 | Citizens | Market Outperform | reiterated | $25.65 | $34 | replaced 2026-06-25, new $36 | +2.1% |
| 2026-06-08 | TD Cowen | Buy | reiterated | $24.78 | $30 | reached 2026-06-11 | -2.9% |
| 2026-06-05 | UBS | Buy | maintained | $24.93 | $49 | replaced 2026-09-18, new $48 | +4.2% |
| 2026-05-21 | Freedom Capital Markets | Buy | initiated | $25.40 | $30 | reached 2026-06-11 | +10.5% |
| 2026-05-14 | Morgan Stanley | Overweight | maintained | $25.15 | $39 | replaced 2026-10-19, new $31 | +9.5% |
| 2026-05-12 | Citigroup | Buy | maintained | $24.61 | $30 | reached 2026-06-11 | +10.7% |
| 2026-05-12 | Mizuho | Outperform | maintained | $24.61 | $45 | running to 2027-05-12 | +10.7% |
| 2026-05-11 | Guggenheim | Buy | maintained | $24.51 | $35 | replaced 2026-08-10, new $33 | +10.3% |
| 2026-05-11 | Barclays | Overweight | maintained | $24.51 | $35 | replaced 2026-08-10, new $34 | +10.3% |
| 2026-05-11 | Needham | Buy | reiterated | $24.51 | $35 | running to 2027-05-11 | +10.3% |
| 2026-05-08 | BTIG | Buy | maintained | $25.52 | $30 | reached 2026-06-11 | +6.6% |
| 2026-04-24 | MoffettNathanson | Buy → Neutral | downgrade | $23.18 | $27 | reached 2026-06-09 | +8.2% |
| 2026-04-21 | Truist Securities | Buy | maintained | $22.99 | $30 | reached 2026-06-11 | -2.9% |
| 2026-04-16 | JPMorgan | Overweight | maintained | $23.74 | $31 | replaced 2026-07-15, new $34 | -5.9% |
| 2026-04-16 | Citigroup | Buy | maintained | $23.74 | $29 | replaced 2026-05-12, new $30 | -5.9% |
| 2026-04-16 | Barclays | Overweight | maintained | $23.74 | $33 | replaced 2026-05-11, new $35 | -5.9% |
| 2026-04-07 | Wells Fargo | Overweight | maintained | $22.95 | $31 | replaced 2026-07-20, new $29 | -8.8% |
| 2026-04-01 | Citizens | Market Outperform | maintained | $22.16 | $34 | replaced 2026-06-25, new $36 | -7.0% |
| 2026-03-31 | Susquehanna | Positive | maintained | $21.62 | $32 | replaced 2026-07-01, new $31 | -9.3% |
| 2026-03-23 | BTIG | Buy | reiterated | $23.96 | $35 | replaced 2026-05-08, new $30 | +7.4% |
| 2026-03-17 | Argus Research | Buy → Hold | downgrade | $25.22 | — | no target | +15.9% |
| 2026-03-16 | UBS | Buy | maintained | $24.90 | $43 | replaced 2026-06-05, new $49 | +14.4% |
| 2026-03-03 | Macquarie | Outperform | maintained | $24.45 | $40 | replaced 2026-08-11, new $38 | -11.1% |
| 2026-03-03 | BMO Capital | Outperform | maintained | $24.45 | $50 | running to 2027-03-03 | -11.1% |
| 2026-03-03 | Citizens | Market Outperform | reiterated | $24.45 | $38 | replaced 2026-04-01, new $34 | -11.1% |
| 2026-03-03 | Needham | Buy | reiterated | $24.45 | $35 | running to 2027-03-03 | -11.1% |
| 2026-03-03 | BTIG | Buy | reiterated | $24.45 | $35 | replaced 2026-05-08, new $30 | -11.1% |
| 2026-02-26 | BTIG | Buy | maintained | $23.49 | $35 | replaced 2026-05-08, new $30 | -22.0% |
| 2026-02-24 | Morgan Stanley | Overweight | maintained | $22.37 | $40 | replaced 2026-05-14, new $39 | -25.4% |
| 2026-02-17 | JPMorgan | Overweight | maintained | $22.59 | $32 | replaced 2026-04-16, new $31 | -30.8% |
| 2026-02-17 | Goldman Sachs | Buy | maintained | $22.59 | $31 | running to 2027-02-17 | -30.8% |
| 2026-02-17 | Stifel | Buy | maintained | $22.59 | $40 | replaced 2026-07-22, new $38 | -30.8% |
| 2026-02-17 | Citigroup | Buy | maintained | $22.59 | $32 | replaced 2026-04-16, new $29 | -30.8% |
| 2026-02-17 | Truist Securities | Buy | maintained | $22.59 | $33 | replaced 2026-04-21, new $30 | -30.8% |
| 2026-02-17 | Barclays | Overweight | maintained | $22.59 | $37 | replaced 2026-04-16, new $33 | -30.8% |
| 2026-02-17 | Mizuho | Outperform | maintained | $22.59 | $44 | replaced 2026-05-12, new $45 | -30.8% |
| 2026-02-17 | Macquarie | Outperform | maintained | $22.59 | $40 | replaced 2026-08-11, new $38 | -30.8% |
| 2026-02-17 | Oppenheimer | Outperform | maintained | $22.59 | $35 | running to 2027-02-17 | -30.8% |
| 2026-02-17 | Needham | Buy | maintained | $22.59 | $35 | running to 2027-02-17 | -30.8% |
| 2026-02-13 | Canaccord Genuity | Buy | maintained | $21.76 | $44 | replaced 2026-10-23, new $40 | -36.6% |
| 2026-02-13 | BTIG | Buy | maintained | $21.76 | $37 | replaced 2026-02-26, new $35 | -36.6% |
| 2026-02-13 | Benchmark | Buy | maintained | $21.76 | $29 | reached 2026-06-11 | -36.6% |
| 2026-02-13 | Bank of America | Neutral | maintained | $21.76 | $30 | reached 2026-06-11 | -36.6% |
| 2026-02-03 | Canaccord Genuity | Buy | maintained | $26.76 | $50 | replaced 2026-02-13, new $44 | -25.0% |
| 2026-01-30 | Stifel | Buy | maintained | $27.51 | $44 | replaced 2026-02-17, new $40 | -20.2% |
| 2026-01-29 | Guggenheim | Buy | maintained | $29.94 | $42 | replaced 2026-05-11, new $35 | -13.9% |
| 2026-01-16 | Morgan Stanley | Overweight | maintained | $32.62 | $53 | replaced 2026-02-24, new $40 | -4.2% |
| 2026-01-15 | Wells Fargo | Equal-Weight → Overweight | upgrade | $35.46 | $49 | replaced 2026-04-07, new $31 | +2.7% |
| 2025-12-22 | Truist Securities | Buy | maintained | $34.90 | $43 | replaced 2026-02-17, new $33 | +16.4% |
| 2025-12-05 | BTIG | Buy | maintained | $34.00 | $45 | replaced 2026-02-13, new $37 | +21.8% |
| 2025-11-19 | Needham | Buy | reiterated | $29.02 | $52 | replaced 2026-02-17, new $35 | — |
| 2025-11-18 | Wells Fargo | Equal-Weight | initiated | $29.37 | $31 | reached 2025-11-25 | — |
| 2025-11-13 | Mizuho | Outperform | maintained | $29.69 | $46 | replaced 2026-02-17, new $44 | — |
| 2025-11-10 | Citigroup | Buy | maintained | $30.54 | $48 | replaced 2026-02-17, new $32 | — |
| 2025-11-10 | Barclays | Overweight | maintained | $30.54 | $40 | replaced 2026-02-17, new $37 | — |
| 2025-11-10 | Macquarie | Outperform | maintained | $30.54 | $48 | replaced 2026-02-17, new $40 | — |
| 2025-11-10 | JPMorgan | Overweight | maintained | $30.54 | $42 | replaced 2026-02-17, new $32 | — |
| 2025-11-10 | Truist Securities | Buy | maintained | $30.54 | $45 | replaced 2025-12-22, new $43 | — |
| 2025-11-10 | Guggenheim | Buy | maintained | $30.54 | $45 | replaced 2026-01-29, new $42 | — |
| 2025-11-10 | Stifel | Buy | reiterated | $30.54 | $46 | replaced 2026-01-30, new $44 | — |
| 2025-11-10 | Susquehanna | Positive | maintained | $30.54 | $48 | replaced 2026-03-31, new $32 | — |
| 2025-11-10 | Bernstein | Outperform | maintained | $30.54 | $41 | replaced 2026-09-03, new $29 | — |
| 2025-11-10 | Needham | Buy | reiterated | $30.54 | $52 | replaced 2026-02-17, new $35 | — |
| 2025-11-07 | Canaccord Genuity | Buy | maintained | $30.40 | $54 | replaced 2026-02-03, new $50 | — |
| 2025-11-07 | Benchmark | Buy | maintained | $30.40 | $37 | replaced 2026-02-13, new $29 | — |
| 2025-11-07 | BTIG | Buy | maintained | $30.40 | $42 | replaced 2025-12-05, new $45 | — |
| 2025-11-04 | BMO Capital | Outperform | maintained | $28.61 | $63 | replaced 2026-03-03, new $50 | — |
| 2025-11-04 | Bank of America | Buy → Neutral | downgrade | $28.61 | $35 | reached 2025-12-04 | — |
| 2025-11-03 | Bernstein | Outperform | maintained | $30.57 | $50 | replaced 2025-11-10, new $41 | — |
Also in Sportsbooks & iGaming
Interactive version with the price chart and target overlay: Scorecard tab on the dashboard. All covered names: index.
How calls are checked
Every call is checked on the firm's own terms. A price target is followed until its own deadline (12 months unless the firm publishes a different horizon) and ends as reached (the stock closed at or beyond it while it stood), replaced (the same firm set a new target first) or short at deadline. A rating is compared with the stock's sector SPDR ETF on total return over the rating's life, because most big-firm ratings are relative: Overweight means "beat its peers", not "go up". Hold-type ratings are tracked, not graded. A firm is numbered only with 30+ resolved targets, and a letter prints only for a firm's whole record where an exact test separates it from a coin flip. None of this is a verdict on anyone's skill, and one day is never a grade. The full method →
Get the daily brief
Our take, the S&P 500 Pulse, the Street's calls and today's docket — one email, weekdays, 9 AM ET, 30 minutes before the open.